Zimmer Biomet (NYSE: ZBH) SVP sells 2,650 shares in open market

Rhea-AI Filing Summary

Zimmer Biomet Holdings senior vice president and chief human resources officer Lori Winkler reported an open-market sale of company stock. She sold 2,650 shares of common stock at an average price of $94.66 per share. After this transaction, she directly holds 10,224 shares of Zimmer Biomet common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Winkler Lori

(Last) (First) (Middle)

345 E. MAIN STREET

(Street)

WARSAW IN 46580

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and CHRO

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/12/2026		S		2,650	D	$94.66	10,224	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Matthew R. St. Louis, Attorney-in-Fact for Lori Winkler (power of attorney previously filed)	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ZIMMER BIOMET (ZBH) report for Lori Winkler?

Lori Winkler reported an open-market sale of Zimmer Biomet shares. The Form 4 shows she sold 2,650 shares of common stock in a single transaction, reflecting a discretionary sale by the company’s SVP and chief human resources officer.

How many ZIMMER BIOMET (ZBH) shares did Lori Winkler sell and at what price?

Lori Winkler sold 2,650 Zimmer Biomet common shares at $94.66 each. The filing describes this as an open-market sale, indicating the shares were sold on the market at that average price per share.

How many ZIMMER BIOMET (ZBH) shares does Lori Winkler hold after the sale?

After the reported sale, Lori Winkler holds 10,224 shares. The Form 4 states this as her direct ownership of Zimmer Biomet common stock following the 2,650-share open-market transaction disclosed in the filing.

What role does insider Lori Winkler have at ZIMMER BIOMET (ZBH)?

Lori Winkler serves as SVP and chief human resources officer at Zimmer Biomet. The Form 4 identifies her as an officer of the company with this title while reporting the recent open-market sale of common stock.

Was the recent ZIMMER BIOMET (ZBH) insider transaction a buy or a sell?

The reported insider transaction was a sale of Zimmer Biomet shares. The Form 4 lists transaction code “S” and describes it as an open-market sale of 2,650 shares of common stock by officer Lori Winkler.

Does Lori Winkler’s ZIMMER BIOMET (ZBH) Form 4 include derivative securities?

The Form 4 does not list any derivative transactions for Lori Winkler. The disclosed activity involves only a non-derivative holding: common stock sold in an open-market transaction, with no options or other derivatives reported in this filing.